首页> 美国卫生研究院文献>Molecular Cancer >Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control
【2h】

Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control

机译:p21WAF1 / CIP1在A549人支气管癌细胞系克隆中的稳定低水平表达下调E2F1 mRNA并恢复细胞增殖控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundDeregulated cell cycle progression and loss of proliferation control are key properties of malignant cells. In previous studies, an interactive transcript abundance index (ITAI) comprising three cell cycle control genes, [MYC × E2F1]/p21 accurately distinguished normal from malignant bronchial epithelial cells (BEC), using a cut-off threshold of 7,000. This cut-off is represented by a line with a slope of 7,000 on a bivariate plot of p21 versus [MYC × E2F1], with malignant BEC above the line and normal BEC below the line. This study was an effort to better quantify, at the transcript abundance level, the difference between normal and malignant BEC. The hypothesis was tested that experimental elevation of p21 in a malignant BEC line would decrease the value of the [MYC × E2F1]/p21 ITAI to a level below this line, resulting in loss of immortality and limited cell population doubling capacity. In order to test the hypothesis, a p21 expression vector was transfected into the A549 human bronchogenic carcinoma cell line, which has low constitutive p21 TA expression relative to normal BEC.
机译:背景失调的细胞周期进程和失去增殖控制是恶性细胞的关键特性。在先前的研究中,包含三个细胞周期控制基因[MYC×E2F1] / p21的交互式转录子丰度指数(ITAI)使用7,000的临界阈值准确区分了正常与恶性支气管上皮细胞(BEC)。在p21与[MYC×E2F1]的二元图上,斜率用7,000的直线表示,恶性BEC在该直线上方,正常BEC在该直线下方。这项研究旨在更好地量化转录本BEC与正常BEC之间的差异。检验了这一假设,即在恶性BEC品系中p21的实验性升高将使[MYC×E2F1] / p21 ITAI的值降至该品系以下的水平,从而导致永生性丧失和有限的细胞群倍增能力。为了检验该假设,将p21表达载体转染到相对于正常BEC具有低组成型p21 TA表达的A549人支气管癌细胞系中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号